Search results
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters via Yahoo Finance· 2 days agoInvestors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19...
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Zacks via Yahoo Finance· 20 hours agoThis is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 24 hours agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 4 days agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 18 hours agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
CNBC· 2 days agoPfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to...
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 20 hours agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
Motley Fool via Yahoo Finance· 3 days agoPfizer stock lost nearly half its value over the past couple of years, but some of the world's most...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks via Yahoo Finance· 22 hours agoFrom a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 1 day agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines